Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06393478
Other study ID # IKVBD-KARD-001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2024
Est. completion date March 1, 2034

Study information

Verified date May 2024
Source Institute for Cardiovascular Diseases "Dedinje"
Contact Ivan S Ilic, MD, PhD
Phone +381641374455
Email ivan1ilic@yahoo.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

SATURATION is a prospective multicenter registry of consecutive patients who undergo coronary physiology testing using Pressure Wire X and Coroflow Coroventis Cardiovascular System software (Abbott Vascular, Abbott Park, IL, USA) and to assess the regional practice of patient selection, cardiovascular outcomes and additional procedures (stress testing, angiography, etc.) done after comprehensive invasive coronary physiology evaluation.


Description:

The study will include adults of both sexes older than 18 years with angina symptoms or angina equivalent referred to cath lab for evaluation of coronary artery disease (CAD) that underwent invasive physiology testing performed (microcirculation testing +/- vasospasm testing) using Coroflow Coroventis Cardiovascular system (Abbott Vascular, Abbott Park, IL, USA) The study will exclude persons under the age of 18, pregnant of nursing ant the ones where no coronary physiology measurements performed . The following data will be collected at enrollment: - De-identified demographic data - Cardiovascular risk factors and significant co-morbidities - Laboratory investigations of interest - Prior cardiovascular events - Pre-procedure medications - Echocardiogram within 3 months of invasive coronary procedure - Non-invasive ischemia testing within 3 months of invasive coronary procedure - Seattle Angina Questionnaire (SAQ) - EQ-5D-5L - Details of the coronary angiography and invasive physiology procedure including procedural complications - Post-procedure medications Data that will be collected during invasive coronary physiology testing: Vasospastic angina testing (which artery, what test, result) Microvascular angina testing (which artery, CFR, IMR, RRR, FFR, Pd, Pa and all transit times) Patients will be seen at follow up visits and the following data will be collected every 6 months for up to 5 years: - Major adverse cardiovascular events including repeat invasive coronary angiography since last follow up - Current medications - SAQ - EQ-5D-5L - Non-invasive ischemia testing since last follow up Outcomes will be evaluated every 6 months for 5 years via direct patient contact by research staff or at follow up visits. Outcomes will be collected based on existing medical documentation. Primary outcomes: - all-cause death and non-fatal MI - composite MACE: all-cause death, non-fatal MI, coronary revascularization, hospitalization for cardiovascular causes (acute coronary syndrome, heart failure, angina, repeated coronary angiography) Secondary outcomes: all-cause death, cardiovascular death, MI, coronary revascularization, stroke, hospitalization for heart failure, hospitalization for acute coronary syndrome, repeated coronary angiography Patient-centered outcomes: - Freedom from angina (SAQ questionnaire) - Quality of life using EQ-5D-5L questionnaire - Follow up non-invasive ischemia testing (if performed)


Recruitment information / eligibility

Status Recruiting
Enrollment 900
Est. completion date March 1, 2034
Est. primary completion date March 1, 2029
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults of both sexes older than 18 years - Angina symptoms or angina equivalent - Referred to Cath lab for evaluation of CAD - Invasive physiology testing performed (microcirculation testing +/- vasospasm testing) using Coroflow Coroventis Cardiovascular system (Abbott Vascular, Abbott Park, IL, USA) Exclusion Criteria: - Persons under the age of 18 - Pregnant of nursing - No coronary physiology measurements performed

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Croatia CHC Rijeka Rijeka
Croatia KBC Zagreb Zagreb
Greece Hippokration Hospital Athens
Greece MITERA General Hospital Athens
Greece Heraklion University Hospital Heraklion
Greece University Hospital of Patras Patras
Israel Tel Aviv Sourasky MC Tel Aviv
Serbia Institute for cardiovascular diseases Dedinje Belgrade
Serbia Institute for cardiovascular diseases Vojvodine Novi Sad
Slovenia UMC Ljubljana Ljubljana

Sponsors (2)

Lead Sponsor Collaborator
Institute for Cardiovascular Diseases "Dedinje" Abbott Medical Devices

Countries where clinical trial is conducted

Croatia,  Greece,  Israel,  Serbia,  Slovenia, 

Outcome

Type Measure Description Time frame Safety issue
Primary all-cause death and non-fatal MI The study will record aggregate number of participants that died and/or suffered from myocardial infarction after invasive physiology procedure 5 years
Primary composite MACE The study will record aggregate number of participants that died from any cause and/or experienced non-fatal myocardial infarction and/or coronary angioplasty procedure and/or hospitalization for cardiovascular causes (acute coronary syndrome, heart failure, angina, repeated coronary angiography) 5 years
Secondary all-cause death The study will record number of participants that died after invasive coronary physiology 5 years
Secondary cardiovascular death The study will record number of participants that died due to cardiovascular causes after invasive coronary physiology 5 years
Secondary myocardial infarction The study will record the number of participants that suffered from myocardial infarction after invasive coronary physiology 5 years
Secondary coronary revascularization The study will record number of participants that undergo surgical and/or percutaneous revascularization after invasive coronary physiology 5 years
Secondary stroke The study will record the number of participants that suffered from stroke after invasive coronary physiology 5 years
Secondary hospitalization for heart failure The study will record the number of participants that are hospitalized for heart failure after invasive coronary physiology 5 years
Secondary hospitalization for acute coronary syndrome The study will record the number of participants that are hospitalized for acute coronary syndrome after invasive coronary physiology 5 years
Secondary repeated coronary angiography The study will record the number of participants that undergo repeated coronary angiography after invasive coronary physiology 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A